2-O-α-D-Glucopyranosyl-l-ascorbic acid as an antitumor agent for infusion therapy

Ascorbic acid (AA) has been reported as a treatment for cancer patients. Intravenous (iv) administration of high-dose AA increases plasma AA levels to pharmacologic concentrations and generates reactive oxygen species (ROS) to exert anti-tumor activity via enhancement of oxidative stress. However, A...

Descripción completa

Detalles Bibliográficos
Autores principales: Miura, Kaori, Tai, Akihiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5614674/
https://www.ncbi.nlm.nih.gov/pubmed/28955751
http://dx.doi.org/10.1016/j.bbrep.2017.04.014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5614674/
https://www.ncbi.nlm.nih.gov/pubmed/28955751
http://dx.doi.org/10.1016/j.bbrep.2017.04.014

Ejemplares similares